Just had a chat with my bro-in-law, who is a research SVP for a large* biosimilars company in the USA - they are, and I quote
Quote:
|
currently preparing a clinical trial at Johns Hopkins and UPenn to kick in the autumn when we expect a resurgence in the northeast
|
No matter what Governments are saying, he says most of the Pharma and biosimilar companies are expecting the 2nd wave September/October, and are planning for that - it’s not just following the science, it’s following the money behind the science.
The company he works for has already started human testing of an experimental Covid-19 antibody cocktail designed as a treatment for the disease, and they should know within a month whether the treatment is effective.
*
market cap of $70 billion